Emergent BioSolutions Inc. (EBS)
Makes vaccines and treatments for bioterrorism and disease outbreaks.
$7.25-0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+28.7%
The outlook
EBS is trading well below its 50- and 200-day moving averages, sitting near the lower end of its 52-week range. Analyst coverage appears thin based on available data. The overall sentiment leans bearish, with the stock positioned in a weak technical zone.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range19% of the way from its 52-week low to high
Market cap
—
52-wk high
$14.06
52-wk low
$5.62
50-day avg
$8.13
200-day avg
$9.65
Trailing P/E
—